| Bid Price | 5.75p | High Price | 6.00p |
|---|
| Ask Price | 6.00p | Low Price | 5.75p |
|---|
| Open Price | 5.88p | Spread | 4.17% |
|---|
| Prev Close | 5.88p | Volume | 57,116 |
|---|
Ondine Biomedical Inc. Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 26, 2024 | 5.88 | 6.00 | 5.75 | 5.88 | 57,116 |
| Apr 25, 2024 | 6.50 | 6.85 | 5.50 | 5.88 | 431,829 |
| Apr 24, 2024 | 6.75 | 7.35 | 6.15 | 6.25 | 553,436 |
| Apr 23, 2024 | 7.00 | 7.00 | 6.50 | 6.75 | 30,379 |
| Apr 22, 2024 | 6.75 | 7.50 | 6.51 | 7.00 | 299,374 |
Ondine Biomedical Inc. Information
| Name | Ondine Biomedical Inc. | Index | FTSE AIM All Share |
|---|
| ISIN | CA68234M2058 | Epic | OBI |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 3,000 | Trading Status | Closed |
|---|
| Shares in Issue | 226.75 m | Prev Close | 5.88p |
|---|
| PE Ratio | | Market Cap | £13.32 m |
|---|
| Div Yield | 0 | Div per Share | NaN CAD |
|---|
| EPS | -0.04 CAD | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.928395 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.341758 | Quick Ratio | 1.711052 |
|---|
Ondine Biomedical Inc. Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 08/12/23 | PLAC | Craig Tooman | NED | 173,278 @ £0.09 | £15,595.00 |
| 08/12/23 | PLAC | Carolyn Cross | CEO | 1,093,770 @ £0.09 | £98,439.00 |
| 08/12/23 | PLAC | Junaid Bajwa | NED | 190,610 @ £0.09 | £17,155.00 |
| 08/12/23 | PLAC | Jean Duvall | NED | 207,934 @ £0.09 | £18,714.00 |
| 08/12/23 | PLAC | Michael Farrar | NED | 86,642 @ £0.09 | £7,798.00 |
Ondine Biomedical Inc. News
